Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Olink Holding AB (publ) OLK NASDAQ

NASDAQ Global Market • Healthcare • Medical - Diagnostics & Research • SE • USD

SharesGrow Score
32/100
0/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$21.50
-17.6%

OLK Insider Ownership

Top Holder
-
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value

No ownership data available for OLK.

People Also View

QGEN
QGEN
Qiagen N.V.
$41.64
-0.29%
 SYNH
SYNH
Syneos Health, Inc.
$42.98
+0.02%
 NEOG
NEOG
Neogen Corporation
$9.42
-1.98%
 CSTL
CSTL
Castle Biosciences, Inc.
$24.62
+1.03%
 ACRS
ACRS
Aclaris Therapeutics, Inc.
$3.93
+0.26%
 GTH
GTH
Genetron Holdings Limited
$4.03
+0.12%
 FONR
FONR
FONAR Corporation
$18.77
+0.05%
 STIM
STIM
Neuronetics, Inc.
$1.39
-2.80%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message